NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
出版年份 2020 全文链接
标题
NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
作者
关键词
-
出版物
BIOSCIENCE REPORTS
Volume 40, Issue 7, Pages -
出版商
Portland Press Ltd.
发表日期
2020-06-24
DOI
10.1042/bsr20200730
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
- (2020) Yi Huang et al. NATURE CELL BIOLOGY
- The Landscape of Targeted Therapies in TNBC
- (2020) Elena Vagia et al. Cancers
- Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production
- (2019) Pawan Kumar Raut et al. BIOCHEMICAL PHARMACOLOGY
- Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
- (2019) Gloria V. Echeverria et al. Science Translational Medicine
- First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer
- (2019) Anna Capasso et al. MOLECULAR CANCER THERAPEUTICS
- Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
- (2019) Dattatrya Shetti et al. Cells
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Combination of Doxorubicin with Gemcitabine-Incorporated GQuadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells
- (2019) Mili Joshi et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion
- (2019) Lingling Si et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MiR‐6838‐5p suppresses cell metastasis and the EMT process in triple‐negative breast cancer by targeting WNT3A to inhibit the Wnt pathway
- (2019) Guozhu Liu et al. JOURNAL OF GENE MEDICINE
- Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer
- (2018) J Zhang et al. ANNALS OF ONCOLOGY
- Single-institution experience with gemcitabine–cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine–S-1 combination therapy: a prospective feasibility study
- (2018) Ryusei Matsuyama et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gemcitabine reduces recurrence
- (2018) Louise Stone Nature Reviews Urology
- NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells
- (2018) Xia Ma et al. PLoS One
- Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer
- (2018) Kai Li et al. Cancer Medicine
- The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
- (2018) Yanfei Jia et al. ONCOGENE
- The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
- (2017) Xiaodong Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
- (2017) Benjamin Weichand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Triple-negative breast cancer and the potential for targeted therapy
- (2017) Jing-Ru Jhan et al. PHARMACOGENOMICS
- Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
- (2017) Cornelia Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasomes and Cancer
- (2017) Rajendra Karki et al. Cancer Immunology Research
- Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition
- (2016) Shweta Shrivastava et al. BIOFACTORS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone
- (2016) Myeongjin Jeon et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
- (2015) Xi-Chun Hu et al. LANCET ONCOLOGY
- Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
- (2015) Stephanie N. Dorman et al. Molecular Oncology
- Breast cancer
- (2015) Chris Woolston NATURE
- NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells
- (2015) Steven W Paugh et al. NATURE GENETICS
- MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer
- (2015) Zhen-Hua Wu et al. TUMOR BIOLOGY
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Subtyping of triple-negative breast cancer: Implications for therapy
- (2014) Vandana G. Abramson et al. CANCER
- TLR-induced PAI-2 expression suppresses IL-1 processing via increasing autophagy and NLRP3 degradation
- (2013) S.-Y. Chuang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudogenes as Weaknesses of ACTB (Actb) and GAPDH (Gapdh) Used as Reference Genes in Reverse Transcription and Polymerase Chain Reactions
- (2012) Yuan Sun et al. PLoS One
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now